These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16327015)

  • 1. Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin.
    Hafstad AD; Solevåg GH; Severson DL; Larsen TS; Aasum E
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1763-9. PubMed ID: 16327015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
    Hafstad AD; Khalid AM; How OJ; Larsen TS; Aasum E
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E; Cooper M; Severson DL; Larsen TS
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice.
    Boardman N; Hafstad AD; Larsen TS; Severson DL; Aasum E
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1373-9. PubMed ID: 19286944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.
    Aasum E; Hafstad AD; Severson DL; Larsen TS
    Diabetes; 2003 Feb; 52(2):434-41. PubMed ID: 12540618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.
    Belke DD; Larsen TS; Gibbs EM; Severson DL
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1104-13. PubMed ID: 11052966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the biochemical mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice?
    Carley AN; Severson DL
    Cardiovasc Drugs Ther; 2008 Apr; 22(2):83-9. PubMed ID: 18247111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
    Carroll R; Carley AN; Dyck JR; Severson DL
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E900-6. PubMed ID: 15632103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter.
    Belke DD; Larsen TS; Gibbs EM; Severson DL
    Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E420-7. PubMed ID: 11171596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
    Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
    Oakes ND; Thalén P; Aasum E; Edgley A; Larsen T; Furler SM; Ljung B; Severson D
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E870-81. PubMed ID: 16352676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.
    Sakamoto J; Barr RL; Kavanagh KM; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1196-204. PubMed ID: 10749714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice.
    Carley AN; Atkinson LL; Bonen A; Harper ME; Kunnathu S; Lopaschuk GD; Severson DL
    Arch Physiol Biochem; 2007 Apr; 113(2):65-75. PubMed ID: 17558605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.
    Mazumder PK; O'Neill BT; Roberts MW; Buchanan J; Yun UJ; Cooksey RC; Boudina S; Abel ED
    Diabetes; 2004 Sep; 53(9):2366-74. PubMed ID: 15331547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid metabolism is enhanced in type 2 diabetic hearts.
    Carley AN; Severson DL
    Biochim Biophys Acta; 2005 May; 1734(2):112-26. PubMed ID: 15904868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial performance and metabolism in non-ketotic, diabetic rat hearts: myocardial function and metabolism in vivo and in the isolated perfused heart under the influence of insulin and octanoate.
    Rösen P; Windeck P; Zimmer HG; Frenzel H; Bürrig KF; Reinauer H
    Basic Res Cardiol; 1986; 81(6):620-35. PubMed ID: 3545178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic remodelling of glucose, fatty acid and redox pathways in the heart of type 2 diabetic mice.
    Cortassa S; Caceres V; Tocchetti CG; Bernier M; de Cabo R; Paolocci N; Sollott SJ; Aon MA
    J Physiol; 2020 Apr; 598(7):1393-1415. PubMed ID: 30462352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats.
    Wall SR; Lopaschuk GD
    Biochim Biophys Acta; 1989 Nov; 1006(1):97-103. PubMed ID: 2804076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic and acute exposure of mouse hearts to fatty acids increases oxygen cost of excitation-contraction coupling.
    Boardman NT; Larsen TS; Severson DL; Essop MF; Aasum E
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1631-6. PubMed ID: 21335471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.
    Neitzel AS; Carley AN; Severson DL
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E357-65. PubMed ID: 12397026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.